Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Frontiers in Oncology|November 5, 2024
A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in IndiaGhazal Tansir, Aparna Sharma, Bivas Biswas, et al.Current Problems in Cancer|March 17, 2020
Utility and safety of maintenance chemotherapy in advanced non-small cell lung cancer across various performance status categories: real-world experienceKuruswamy Thurai Prasad, Valliappan Muthu, Bivas Biswas, et al.The National Medical Journal of India|October 2, 2021
Clinicopathological characteristics, prognostic factors and treatment outcomes of seminomatous germ cell tumours from a tertiary cancer centre in eastern IndiaDeepak Dabkara, Sandip Ganguly, Joydeep Ghosh, et al.Current Problems in Cancer|February 10, 2020
Immune checkpoint inhibitors in advanced non-small cell lung cancer: A metacentric experience from IndiaSantosh Kumar, Srujana Joga, Bivas Biswas, et al.Pediatric Blood & Cancer|December 16, 2022
Determinants and impact of diagnostic interval in bone sarcomas: A retrospective cohort studyArchana Sasi, Shuvadeep Ganguly, Bivas Biswas, et al.Journal of Surgical Oncology|January 6, 2015
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocolBivas Biswas, S Rastogi, S A Khan, et al.Cureus|June 16, 2025
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian PerspectiveBoman Dhabhar, Prabrajya N Mahapatra, Vamshi M Krishna, et al.Ecancermedicalscience|October 21, 2024
Pattern of care and treatment outcomes of metastatic non-clear cell kidney cancer: a single centre experience from IndiaSomnath Roy, Sreejata Raychaudhuri, Bivas Biswas, et al.Ecancermedicalscience|November 26, 2021
Multidisciplinary management of ovarian germ cell tumours-a single institutional study from IndiaSandip Ganguly, Sumedha Gargy, Archisman Basu, et al.JCO Global Oncology|March 4, 2020
Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and FacetsAmol Patel, Ian F Tannock, Priyanka Srivastava, et al.Pageof 8